phyto chem india ltd share price Management discussions

M/s Phyto Chem (India) Limited has been carrying on the business predominantly in two segments i.e. Pesticides Formulations and Real Estate activities.

Pesticides play a key role in agriculture in India and have contributed to the growth of the agriculture sector over the last several decades. The Company has created good manufacturing facilities for high-quality products and has consistently-contributed to the rural community. The Real Estate activity holding good promise to achieve better yielding. The Company has discontinued the marketing of Food Products business during the year under review due to intense competition, challenges from the existing firms and large expenditures on advertising to promote the business.

The SWOT Analysis is as follows:

1. Strengths:

- The Company has established a Brand for qualitative products of pesticides and also has developed a network in grassroots level marketing. Government policies are inherently in favour of our products because the nation is primarily agricultural, which is positive development. The growth in Real Estate activity in the country is a positive sign for greater prospects.

2. Weakness:

- Untimely rain and unfavourable climatic conditions, as well as unhealthy rivalry, an unconstrained credit period for dealers and a pricing war in the trade, all contribute to variations in pesticide marketing.

- The economys Inflation and declining demand may have an influence on Real Estate projects.

3. Opportunities:

- Favorable government policies in the agriculture sector, as well as the introduction of new farmer incentives, would generate good opportunities for our Company. This will aid in the development of farming communitys purchasing power and the creation of demand for our products. Real Estate activity in the country is continuously increasing, particularly in urban and metro areas, which will help to capitalize on the opportunities available.

4. Threats:

- The competition from big players, price wars, spurious products of pesticides, change in Government policies and interest rates.

- Increase in prices of Land and interest rates has impacted the countrs demand for Real Estate activity.

5. Financial Analysis:

The Companys financial analysis is presented in the Directors Report under section Review of Operations.

6. Future Outlook:

- The Company tries to continue its focus on product and its quality development and also to penetrate into key markets.

- Company exploring new opportunities for diversification and expansion into new business areas like construction and trading activities etc.

7. Internal Control Procedures:

The Company has an Audit Committee and has the mechanism to review the Internal Audit Control procedures. Periodic Audits of the Accounts are carried out internally to attain the object of internal procedures. The Company has also appointed M/s R. B. Associates., Chartered Accountants as Internal Auditors of the Company to conduct internal audit on the Accounts and procedural Compliances.

8. Human Resources:

The Company has capable and experienced employees as well as dedicated management. Human relations with the personnel remain positive. Employees receive in-house training to help encourage them contribute to increased production. The Companys human resources are regarded as vital assets.

9. Cautionary Statement:

The statements in the Management Discussion and Analysis describing the Companys objectives, projections, estimates or expectations may be considered "forward-looking" statements under applicable Securities, Laws and Regulations. The actual results could differ materially from those expressed or implied and the achievement of results is subject to risks, uncertainties, economic conditions, demand/ supply and price factors that may influence the operations of the Company.

Conservation of Energy, Technology Absorption, Foreign Exchange and Outgo. Information undei Section 134 of the Companies Act, 2013 read with rule 8 of the Companies (Accounts) Rules, 2014 and forming part of Boards Report for the year ended 31st March 2023.

A. Conservation of Energy:

The Company has been putting regular efforts to improve Energy efficiency through Energy Conservation Measures.

i. Energy conservation measures taken:

* The Company has carried out various measures to optimize energy consumption.

* The Company has replaced conventional electrical cables, MCBs etc. with latest Electrical items.

ii. Impact of measures taken:

* Reduction in annual diesel oil consumption.

* Continuous alertness of power saving.

iii. Steps taken for utilizing alternate sources of the energy:

* Company is evaluating the economic viability for installation of Solar Street Lights and Solar panels for Plant Lighting.

iv. Capital investment on Energy conservation equipments:

* Capital Expenditure has not been accounted for separately.

B. Technology Absorption:

Research and Development (R&D):

i. Effects in brief made towards Technology Absorption:

* The Company has adopted Indigenous Technology for manufacture of Pesticides Formulations anc no imported technology is involved.

* The Company has an In-house R&D division for improving the quality, productivity and for developing the new viable products.

ii. Benefits derived as a result of the above efforts:

* Improvement in product quality and productivity.

* Enhanced products range to address emerging market opportunities.

iii. Imported technology (imported during the last three years reckoned from the beginning of the financia year):

* Not applicable as no technology was imported during the last three years.

iv. Expenditure incurred on Research and Development:

* R & D Expenditure has not been accounted for separately.

C. Foreign Exchange Earnings and Outgo:

During the year, there were no exports. The export market for pesticide formulations is not encouraging due to thin margins and heavy competition from Technical Pesticide Manufacturers.

i. Total Foreign Exchange outflow:

Equivalent to Rs.124.03 lakhs (USD 1.56 lakhs) towards Raw materials.

ii. Total Foreign Exchange inflow:

Equivalent to Rs.Nil (USD Nil) towards Exports of Pesticides Formulations.

Corporate Governance Report

1. Companys Philosophy on Corporate Governance:

The Board lays strong emphasis on attainment of high levels of Transparency, Accountability and Integrity and the corporate actions, which balance the interest of the stakeholders. The Company has adopted a code of conduct for Members of the Board, Senior Management and Key Managerial Personnel, who have all affirmed in writing their adherence to the Code.

2. Board of Directors:

The Board of Directors comprises of 10 Directors of which 3 are Promoter Directors. viz. Dr. P Sreemannarayana, Mr. Y Nayudamma and Dr. Y Venkateswarlu. Five Board Meetings were held during the period from April 2022 to March 2023 on the following dates:

28th May 2022, 08th August 2022, 28th September 2022, 31st October 2022, and 14th February 2023.

The Attendance of the Directors at Meetings and Number of other Directorships:



Name of the Director



Number of Board Meetings attended Attendance of last AGM (Yes/No) Other



Dr. P. Sreemannarayana



5 Ye s 2


Mr. Y. Nayudamma


E & NI

5 Yes 4


Mr. Y. Janaki Ramaiah


E & NI

5 Yes 1


Dr. Y. Venkateswarlu



1 No -

Mr. K. Srinivasa Rao




0 No 1


Mr. P. Anjaneyulu



2 No 3


Dr. G. S. R. Anjaneyulu


NE & I

3 No -


Mr. M. Sree Ram Murthy


NE & I

5 Yes 3


Mr. K. Ravindra Babu


NE & I

3 Ye s 1


Mr. S.Y. Sampath Kumar


NE & I

5 Ye s 3


Mrs. G. Vijitha


NE & I

5 Ye s 2

NE = Non-Executive, I = Independent, E = Executive, NI = Non - Independent.

None of the Directors on the Board is a member of more than 10 Committees and Chairman of more than 5 Committees across all the Companies in which they are Directors.

3. Code of Conduct:

Pursuant to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board has suitably modified the ‘Code of Conduct for Board of Directors, Senior Management and Key Managerial Personnel (Code of Conduct) and is available on the Companys website. The Directors, Key Managerial Personnel and Senior Management Personnel have affirmed their compliance with the Code of Conduct as at 31st March 2023.

4. Audit Committee:

The Company has a qualified and independent Audit Committee comprising of five non-executive Independent Directors, constituted in accordance with the provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 entered with the Stock Exchange and Section 177 of the Companies Act, 2013. The role, terms of reference, authority and powers of the Audit Committee are in conformity with the requirements of the Companies Act, 2013 and Listing Agreement.

The Committee held Four meetings during the year 2022-23 i.e. on 28th May 2022, 08th August 2022, 31st October 2022 and 14th February 2023 and the attendance at the meetings of the members was as under:

S.No. Name of the Member Attendance Particulars Category
1. Dr. G. S. R. Anjaneyulu 3 Chairman
2. Mr. M. Sree Ram Murthy 4 Member
3. Mr. K. Ravindra Babu 2 Member
4. Mr. S. Y Sampath Kumar 4 Member
5. Mrs. G. Vijitha 4 Member

The Audit Committee discussed with the Statutory Auditors on the "Limited Review" of the quarterly/ half- yearly/ yearly accounts, the audit plan for the year, matters relating to compliance with accounting standards, the Auditors observations arising from the Annual Audit of the Companys accounts and other related matters.

5. Nomination and Remuneration Committee:

The Nomination and Remuneration Committee held two meetings during the year 2022-23 i.e., 08th August 2022 and 14th February 2023 with the following members :

Sl.No. Name of the Member Attendance Category
1. Mr. M. Sree Ram Murthy 2 Chairman
2. Dr. G. S. R. Anjaneyulu 2 Member
3. Mr. K. Ravindra Babu - Member
4. Mr. S. Y Sampath Kumar 2 Member
5. Mrs. G. Vijitha 2 Member

Remuneration Policy:

Remuneration Policy of the Company is summarised as follows:

a. Policy for Selection and Appointment of Directors and their Remuneration:

The Remuneration Committee has adopted a Charter which, inter-alia, deals with the manner of selection of Board of Directors and Executive Directors and their remuneration.

b. Criteria of Selection of Non-Executive Directors:

The Non-Executive Directors shall be of high integrity with relevant expertise and experience so as to have a diverse Board with Directors having expertise in the fields of manufacturing, marketing, finance, taxation, laws, governance and general management.

In case of appointment of Independent Directors, the Remuneration Committee shall satisfy itself with regard to the independent nature of the Directors vis-a-vis the Company so as to enable the Board to discharge its functions and duties effectively.

The Remuneration Committee shall ensure that the candidate identified for appointment as a Director is not disqualified for appointment under Section 164 of the Companies Act, 2013. The Remuneration Committee shall consider the following attributes/ criteria, whilst recommending to the Board the candidature for appointment as Director.

i. Qualification, expertise and experience of the Directors in their respective fields;

ii. Personal, Professional or Business standing;

iii. Diversity of the Board.

In case of reappointment of Non Executive Directors, the Board shall take into consideration the performance evaluation of the Director and his engagement level.

c. Remuneration:

i. For Managing Director and Executive Director:

The total remuneration payable to Managing Director and Executive Director is subject to Shareholders approval and consists of Salary, Allowances. Perquisites and Benefits are in line with the Companys rules for Senior Managerial Personnel and Key Managerial Personnel.

ii. For Non-Executive Directors:

Sitting Fees is paid as per applicable provisions of the Companies Act, 2013 and rules made thereunder and the Articles of Association of the Company for attending meetings of the Board or any committees of the Board. The Directors are also reimbursed with actual travel costs and incidental expenses incurred for attending such meetings or in connection with the Companys business. The Chairman of the Company is reimbursed with the cost of travel and expenses incurred for attending Board and General Meetings.

The details of Remuneration of Directors during the period under review are as follows: (Rs. in lakhs)



Name of the Director

Relationship with other Directors



Commission on profits Salary and allowances Perquisites Total


Dr. P. Sreemannarayana


0.25 0.25


Mr. Y. Nayudamma


32.12 32.12


Mr.Y. Janaki Ramaiah


20.10 20.10


Mr. P. Anjaneyulu


0.10 0.10


Dr. Y. Venkateswarlu


0.05 0.05

a. Mr. K. Srinivasa Rao



Dr. G. S. R. Anjaneyulu

0.29 0.29


Mr. M. Sree Ram Murthy

0.40 0.40


Mr. K. Ravindra Babu

0.20 0.20


Mr. S. Y. Sampath Kumar

0.40 0.40


Mrs. G. Vijitha

0.40 0.40

Sitting fee to Non-executive Directors is Rs.5,000/- for each Board meeting, Rs.1,500/- for each Audit Committee, Nomination and Remuneration Committee, Performance Evaluation Committee, Risk Management Committee, Stakeholders Relationship Committee, Independent Directors Committee and Share Transfer Committee meetings.

6. Performance Evaluation Committee:

The Performance Evaluation Committee met once on 14th February 2023 during the year 2022-23. The attendance record of the members at the meeting was as follows:

Sl.No. Name of the Member Attendance Category
1 Mr. K. Ravindra Babu - Chairman
2. Dr. G. S. R. Anjaneyulu 1 Member
3. Mr. M. Sree Ram Murthy 1 Member
4. Mrs. G. Vijitha 1 Member
5. Mr. S.Y. Sampath Kumar 1 Member

7. Risk Management Committee:

The Risk Management Committee met once on 14th February 2023 during the year 2022-23. The attendance record of the members at the meeting was as follows:

Sl.No. Name of the Member Attendance Category
1. Mr. Y. Nayudamma 1 Chairman
2. Dr. G. S. R. Anjaneyulu 1 Member
3. Mr. M. Sree Ram Murthy 1 Member
4. Mr. K. Ravindra Babu - Member
5. Mrs. G. Vijitha 1 Member
6. Mr. S.Y Sampath Kumar 1 Member

Business Risk and Management is ongoing process within the Organization. The Company has proper risk management framework to identify, monitor and minimise risks and also identify business opportunities. The objectives and scope of the Risk Management Committee broadly comprises of:

a. Oversight of risk management performed by the Executive Management;

b. Reviewing the Business Risk and Management Policy and framework in line with local legal requirements and SEBI guidelines;

c. Reviewing risks and evaluate treatment including initiating mitigation actions and ownership as per a predefined cycle;

d. Defining framework for identification, assessment, monitoring, mitigation and reporting of risks; within its overall scope as aforesaid, the Committee shall review risks, trends, exposure and potential impact analysis and mitigation plan.

8. Independent Directors Committee Meeting:

During the year under review, the Committee comprises of Mr. S. Y. Sampath Kumar as Chairperson, Dr. G. S. R. Anjaneyulu, Mr. M. Sree Ram Murthy, Mr. K. Ravindra Babu and Mrs. G. Vijitha as its members. The members met once on 14th February 2023 inter-alia, to discuss the following items of business:

a. Evaluation of the performance of the Non-Independent Directors and the Board of Directors as a whole.

b. Evaluation of the performance of the Chairman of the Company taking into account the views of the Executive and Non Executive Directors;

c. Evaluation of the quality, contents and timelines of flow of information between the Management and the Board that is necessary for the Board to effectively and reasonably perform its duties.

9. a. Stakeholders Relationship Committee:

The Stakeholders Relationship Committee comprises of Mrs. G. Vijitha as Chairman, Dr. G. S. R. Anjaneyulu, Mr. M. Sree Ram Murthy, Mr. K. Ravindra Babu, Mr. S. Y Sampath Kumar and Mr. Y Nayudamma as its Members. The Committee met once on 28th May 2022 during the year 2022-23.

All the complaints were redressed and no complaints received during the year were pending either in the beginning or ending of the year. The details are given below:



Nature of Complaints. No. of letters received No. of letters resolved/ replied Pending/


1. No. of requests for Change of Address 0 0 0
2. Non-receipt of Share Certs./ Bonus Shares 0 0 0
3. Issue of Duplicate Share Certificates 4 4 0
4. Non-receipt of Demat Confirmations/ Rejections 0 0 0
5. Transmission of shares 1 1 0
5. Revalidation of Refund Orders/ Dividend Warrants 0 0 0
6. Non - receipt of Dividend Warrants 0 0 0
7. Other letters 10 10 0

During the year, there are no other investors grievances pending in respect of transfers, letters from SEBI & Stock Exchange.

b. Share Transfer Committee:

The Share Transfer Committee comprises of Mr. Y. Nayudamma as Chairman, Mr. Y. Janaki Ramaiah as Convenor, Mr. B. Sambasiva Rao as Member, and Mr. Pavansingh Thakur as Compliance Officer.

10. General Body Meetings:

The last three Annual General Meetings (AGM) and one Extra Ordinary General Meeting (EGM) of the Company were held at the Registered Office of the Company at Survey No.628, Temple Street, Bonthapally- 502 313, Gummadidala Mandal, Sangareddy District, Telangana State.

i. 28th December 2020 at 11:45 A.M. - AGM

ii. 27th September 2021 at 11:45 A.M. - AGM

iii. 28th September 2022 at 11:45 A.M. - AGM

iv. 12th May 2023 at 04.00 P.M. - EGM

No postal ballots were used/ invited for voting at these meetings in respect of the Special Resolutions required to be passed nor they are proposed at the ensuing Annual General Meeting.

11. Dematerialisation of Shares and Liquidity:

As on 31st March 2023, 82.31 % of the shares of your Company have been dematerialised. As the trading of/ transfer of your Company shares are being conducted only in electronic form and all other members holding shares in physical form are requested to convert their shareholdings to electronic form at the earliest.

12. Disclosures under Sexual Harassment of Women at workplace (Prevention, Prohibition and Redressal) Act, 2013:

Your Company has complied with provisions relating to the constitution of Internal Complaints Committee under the Sexual Harassment of women at workplace (Prevention, Prohibition and Redressal) Act, 2013. There are no cases filed/ complaints lodged in the Company during the year under review in respect of the Sexual Harassment of Women at workplace.

13. Disclosures:

Pecuniary disclosure with regard to interested Directors:

a. Disclosures on materially significant related party transactions of the Company of material nature, with its Promoters, the Directors or the Management, their Subsidiaries or Relatives, that may have potential conflict with the interests of the Company at large:-

None of the transactions with any of related parties was in conflict with interest of the Company.

b. Details of non-compliance by the Company and the penalties, strictures imposed on the Company by Stock Exchange or SEBI or any Statutory Authority, on any matter related to Capital Markets during the last three years:-

There were no instances of non-compliance of any matter related to Capital Market during the last three years and no penalties or fines imposed by any Statutory Authorities.

c. Compliance Certificate of the Auditors:

Certificate of the Statutory Auditors has been obtained on the compliance of the conditions of Corporate Governance in terms of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 with Stock Exchanges and the same is annexed.

d. Details of compliance with mandatory requirements and adoption of the non-mandatory requirements of this clause:

The Company has fully complied with the mandatory requirements of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 of the Stock Exchange.

e. The Management Discussion and Analysis is a part of this Annual Report.

f. Certificate from Company Secretary in Practice:

M/s. Vijendra& Co., Practicing Company Secretaries , have issued a certificate as required under the Listing Regulations, confirming that none of the Directors on the Board of the Company has been debarred or disqualified from being appointed or continuing as Director of Companies by the SEBI/ Ministry of Corporate Affairs or any such statutory authority. The certificate is enclosed with this section as Annexure - A.

14. Means of Communication:

a. The Company publishes its quarterly, half yearly and annual results in the Business Standard and Andhra Prabha (Telugu).These results are submitted to the Stock Exchange in accordance with the provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

b. Website :

c. E-mail Id :

15. General information for members:

a. Thirty Fourth Annual General Meeting:

Date, Time and Venue: Monday, the 07th day of August 2023 at 11:30 A.M.
M/s Phyto Chem (India) Limited, Regd. Office: Survey No.628,
Temple Street, Bonthapally - 502 313, Gummadidala Mandal,
Sangareddy District, Telangana State.

b. Financial Calendar:

Results For 2022-23 were announced on For 2023-24 will be announced by
First Quarter 08th August 2022 14th August 2023
Second Quarter/ Half Year 31st October 2022 14th November 2023
Third Quarter 14th February 2023 14th February 2024
Yearly- Audited Results 27th May 2023 30th May 2024

c. Dates of Book Closure:

0151 August 2023 to 07th August 2023 both days inclusive.

d. Dividend Payment Date: Not Applicable

e. i. Stock Exchanges where listed:

M/s. BSE Limited, P. J. Towers, Dalal Street, Mumbai - 400 001. ii. Stock Code (BSE): 524808 f Market Price Data:

The market price data High/ Low during each month in the last financial year (2022-23) at the M/s. BSE Limited, Mumbai is as follows:-


Bombay Stock Exchange Limited

High-in Rs. Low-in Rs. Volume - No.of Shares

April 2022

25.60 19.55 30,573

May 2022

26.45 20.35 7,244

June 2022

23.30 18.40 6,171

July 2022

24.00 20.20 4,090

August 2022

20.45 18.15 17,527

September 2022

22.65 16.45 89,754

October 2022

24.40 19.45 45,744

November 2022

36.10 24.60 1,26,587

December 2022

47.80 31.00 3,22,934

January 2023

83.20 49.25 5,34,923

February 2023

74.90 35.80 1,60,705

March 2023

39.50 25.79 1,27,435

g. Share Transfer Agent:

M/s. Bigshare Services Private Limited, 306, 3rd Floor, Right Wing, Amrutha Ville, Opp: Yashoda Hospital, Somajiguda, Rajbhavan Road, Hyderabad - 500 082, Ph.No. 040-23374967.

h. Distribution of Shareholding by ownership as on 31-03-2023:

Sl. No. Shareholding pattern Shares Shareholding %
1 Promoters 1,737,309 40.40
2 Indian Public 2,216,806 51.55
3 Mutual Funds 8,000 0.19
4 Body Corporates 256,859 5.97
5 NRI- Non Promoters 79,246 1.84
6 Clearing Members 1,980 0.05
Total: 4,300,200 100.00

i. Distribution of Shareholding by size as on 31-03-2023:

Range of shares

No.of shareholders No.of shares % of shareholders % of holding

Upto 500

6,599 834,239 91.82 19.40


256 215,039 3.56 5.00


142 215,084 1.98 5.00


48 118,769 0.67 2.76


26 93,865 0.36 2.18


20 92,389 0.28 2.15


37 273,060 0.51 6.35

10001 and above

59 2,457,755 0.82 57.16


7,187 4,300,200 100.00 100.00

j. Your Company has not issued any GDRs/ ADRs/ Warrants or any convertible instruments or ESOPs.

k. Plant Location:

Survey No.628, Temple Street, Bonthapally - 502 313. Gummadidala Mandal, Sangareddy District, Telangana State.

l. Compliance with the Regulation 39(4) read with Schedule VI of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015:

There are no shares issued pursuant to Public Issue or any other issue which remain unclaimed.

m. Address for Correspondence :

Shareholders Correspondence may be made with the Companys Share Transfer Agents at the address given at 15.g. above. In case of any difficulty, shareholders may contact Mr. Pavansingh Thakur, Compliance Officer at the Corporate Office at No.8-3-229/23, First Floor, Thaherville, Yousufguda Checkpost, Hyderabad - 500 045, Telangana, at e-mail:

The Report has not covered the non-mandatory requirements of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.